ERGORESEARCH ANNOUNCES THE APPOINTMENT OF ITS NEW VICE PRESIDENT FINANCE
Published November 28 2014 in What's New
LAVAL, November 28, 2014 – Ergoresearch Ltd « Ergoresearch » (TSX Venture: ERG) is pleased to announce the appointment of Mrs. Dominique Boudreau who will hold the position of Vice-Président Finance among its management team. Mrs. Dominique Boudreau was acting as corporate controler of the group since January 2013 and occupied similar duties for more than seven years for Laboratoire Langelier, a company acquired by the Ergioresearch Ltd in January 2013. Mrs. Boudreau replaces Mr. Greco who was previously appointed Chief Financial Officer in April 2014. Mr. Greco left to pursue new goals.
Mrs. Boudreau is a registered member of the Quebec chartered accountants and holds an MBA from the University of Sherbrooke.
Ergoresearch is a Canadian company that designs and manufactures cutting edge technologies for the orthopedic industry. The Company holds a portfolio of
patents in the bionics field, including the intellectual property used in the Power Knee, the world’s only motor-powered AI prosthesis for above-knee amputees.
Ergoresearch designed and commercialized WebFit™, the first robotized custom-fit orthotics manufacturing software program and launched OdrA, a new
category of orthotic that, with the action of its world-patented distraction-rotation action, revolutionizes the treatment of pain associated with knee osteoarthritis.
Ergoresearch owns the largest orthotics network in Quebec, now known as Equilibre. The Corporation is listed on the TSXVenture Exchange under the ERG
This document is not intended to encourage the purchase of securities listed on the TSX Venture Exchange. TMX Group and its affiliates do not endorse or recommend any of the securities referenced here. Please seek professional advice to evaluate specific securities.
Certain statements in this Press Release contain forward-looking statements and information that may entail certain risks related to uncertainties. Such
statements are based on management’s expectations and no assurance can be given that potential future results or circumstances described in the forward
looking statements will be achieved or will occur, as these statements are subject to numerous uncertainties and risk factors. Such risk factors include, but are
not limited to, those related to the Company’s ability to finance its activities, competition, ability to negotiate and maintain partnerships, the market acceptance of
the Company’s product, the strength of intellectual property, the success of research and development programs, the trust invested in sub-contractors or their
core personnel as well as other risks and uncertainties that are put forth every now and then by the Company in the documents filed with various Canadian
securities and exchange commissions and made available at www.sedar.com.
The reader should not give great importance to forward-looking statements as (i) the results may differ from conclusions, predictions or projections contained in
such forward-looking statements; and (ii) certain important factors or hypotheses taken into account in reaching conclusions or the preparation of a projection or
prediction may prove to be incorrect in fact.
These statements are correct only on the date on which they were written, and Management disclaims any obligation to revise these statements after any event,
circumstance or other situation, except as required by law. All figures are in Canadian dollars, unless otherwise specified.
Neither TSX Venture Exchange nor itsRegulation ServicesProvider (as that term isdefined in the policiesof the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Sylvain Boucher, President and CEO – Ergoresearch Ltd
Tel.: 450-973-6700, x. 213 / email@example.com